E-LIB Suche - Ergebnisse für: Lingas, Guillaume

1

Preclinical in vivo assessment of the activity of AZD7442 a..:

Driouich, Jean-Sélim ; Cochin, Maxime ; Lingas, Guillaume...
Biomedicine & Pharmacotherapy. 177 (2024) - p. 116988 , 2024

Link: https://doi.org/10.1016/..

2

Neutralizing Antibody Levels as a Correlate of Protection A..:

Lingas, Guillaume ; Planas, Delphine ; Péré, Hélène...
Clinical Pharmacology & Therapeutics. 115 (2023) 1 - p. 86-94 , 2023

Link: https://doi.org/10.1002/..

3

Association between SARS‐CoV‐2 viral kinetics and clinical ..:

Néant, Nadège ; Lingas, Guillaume ; Gaymard, Alexandre...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 12 - p. 2027-2037 , 2023

Link: https://doi.org/10.1002/..

4

High sera levels of SARS‐CoV‐2 N antigen are associated wit..:

Chenane, Houssem Redha ; Lingas, Guillaume ; Menidjel, Reyene...
Journal of Medical Virology. 95 (2023) 11 - p. , 2023

Link: https://doi.org/10.1002/..

5

Effect of remdesivir on viral dynamics in COVID-19 hospital..:

Lingas, Guillaume ; Néant, Nadège ; Gaymard, Alexandre...
Journal of Antimicrobial Chemotherapy. , 2022

Link: https://doi.org/10.1093/..

6

Antiviral efficacy of favipiravir against Zika and SARS-CoV..:

Marlin, Romain ; Desjardins, Delphine ; Contreras, Vanessa...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

7

Lassa viral dynamics in non-human primates treated with fav..:

Lingas, Guillaume ; Rosenke, Kyle ; Safronetz, David..
PLOS Computational Biology. 17 (2021) 1 - p. e1008535 , 2021

Link: https://doi.org/10.1371/..

8

Survival of SARS-CoV-2 on Non-Porous Materials in an Experi..:

Bonil, Laura ; Lingas, Guillaume ; Coupeau, Damien...
Coatings. 11 (2021) 4 - p. 371 , 2021

Link: https://doi.org/10.3390/..

9

Modeling SARS-CoV-2 viral kinetics and association with mor..:

Néant, Nadège ; Lingas, Guillaume ; Le Hingrat, Quentin...
Proceedings of the National Academy of Sciences. 118 (2021) 8 - p. , 2021

Link: https://doi.org/10.1073/..

10

Favipiravir antiviral efficacy against SARS-CoV-2 in a hams..:

Driouich, Jean-Sélim ; Cochin, Maxime ; Lingas, Guillaume...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

11

Neutrophil Activation and Immune Thrombosis Profiles Persis..:

Hocini, Hakim ; Wiedemann, Aurélie ; Blengio, Fabiola...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s10875-023-01459-x. , 2023

Link: https://hal.science/hal-..

12

Neutralizing antibody levels as a correlate of protection a..:

Lingas, Guillaume ; Planas, Delphine ; Péré, Hélène...
info:eu-repo/semantics/altIdentifier/doi/10.1002/cpt.3069. , 2023

Link: https://pasteur.hal.scie..

13

Neutralizing antibody levels as a correlate of protection a..:

Lingas, Guillaume ; Planas, Delphine ; Péré, Hélène...
info:eu-repo/semantics/altIdentifier/doi/10.1002/cpt.3069. , 2023

Link: https://pasteur.hal.scie..

14

Neutralizing antibody levels as a correlate of protection a..:

Lingas, Guillaume ; Planas, Delphine ; Péré, Hélène...
info:eu-repo/semantics/altIdentifier/doi/10.1002/cpt.3069. , 2023

Link: https://pasteur.hal.scie..

15

Neutralizing antibody levels as a correlate of protection a..:

Lingas, Guillaume ; Planas, Delphine ; Péré, Hélène...
info:eu-repo/semantics/altIdentifier/doi/10.1002/cpt.3069. , 2023

Link: https://pasteur.hal.scie..